Vistagen therapeutics, inc. announced that it expects to receive $0.6 million in funding

Vistagen therapeutics, inc. (nasdaqcm:vtgn) announced a private placement of 300,000 units at the price of $2 per unit for gross proceeds of $600,000 on october 30, 2019. the company is accepting subscription from accredited investors for units, each consisting of one unregistered share of common stock and a warrant to purchase one-half of one share of unregistered common stock at an exercise price of $2.00, for a purchase price of $1.00 per unit to certain accredited investors.
VTGN Ratings Summary
VTGN Quant Ranking